GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CXI Healthcare Technology Group Ltd (XKRX:900120) » Definitions » Cash Flow from Financing

CXI Healthcare Technology Group (XKRX:900120) Cash Flow from Financing : ₩962 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CXI Healthcare Technology Group Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, CXI Healthcare Technology Group paid ₩0 Mil more to buy back shares than it received from issuing new shares. It received ₩46 Mil from issuing more debt. It paid ₩0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ₩0 Mil from paying cash dividends to shareholders. It received ₩1,043 Mil on other financial activities. In all, CXI Healthcare Technology Group earned ₩1,088 Mil on financial activities for the three months ended in Dec. 2024.


CXI Healthcare Technology Group Cash Flow from Financing Historical Data

The historical data trend for CXI Healthcare Technology Group's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CXI Healthcare Technology Group Cash Flow from Financing Chart

CXI Healthcare Technology Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 694.07 742.78 1,155.91 1,456.41 252.81

CXI Healthcare Technology Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -564.50 -285.57 61.99 105.19 1,079.92

CXI Healthcare Technology Group Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

CXI Healthcare Technology Group's Cash from Financing for the fiscal year that ended in Jun. 2024 is calculated as:

CXI Healthcare Technology Group's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩962 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CXI Healthcare Technology Group  (XKRX:900120) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

CXI Healthcare Technology Group's issuance of stock for the three months ended in Dec. 2024 was ₩0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

CXI Healthcare Technology Group's repurchase of stock for the three months ended in Dec. 2024 was ₩0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

CXI Healthcare Technology Group's net issuance of debt for the three months ended in Dec. 2024 was ₩46 Mil. CXI Healthcare Technology Group received ₩46 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

CXI Healthcare Technology Group's net issuance of preferred for the three months ended in Dec. 2024 was ₩0 Mil. CXI Healthcare Technology Group paid ₩0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

CXI Healthcare Technology Group's cash flow for dividends for the three months ended in Dec. 2024 was ₩0 Mil. CXI Healthcare Technology Group received ₩0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

CXI Healthcare Technology Group's other financing for the three months ended in Dec. 2024 was ₩1,043 Mil. CXI Healthcare Technology Group received ₩1,043 Mil on other financial activities.


CXI Healthcare Technology Group Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of CXI Healthcare Technology Group's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


CXI Healthcare Technology Group Business Description

Traded in Other Exchanges
N/A
Address
Century Yard, Cricket Square, PO Box 902, 3rd Floor, Grand Cayman, CYM, KY1-1103
CXI Healthcare Technology Group Ltd is a food manufacturing and distribution company. It operates through subsidiaries that manufacture nutritional supplements. The company's products include Traditional Chinese medicines in the form of a capsule, drinks, and tea. All of its products are marketed only in China.

CXI Healthcare Technology Group Headlines

No Headlines